Ignite Creation Date:
2025-12-24 @ 4:55 PM
Ignite Modification Date:
2026-01-22 @ 1:07 PM
Study NCT ID:
NCT00853450
Status:
COMPLETED
Last Update Posted:
2009-08-19
First Post:
2009-02-27
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Bleeding Time Study With AZD6482, Clopidogrel and ASA
Sponsor:
AstraZeneca
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
D1700C00004
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Peter Held, Medical Science Director, Early Thrombosis & Haemostasis
Old Organization:
AstraZeneca